LifeStance Health (LFST) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $11.74, -5.09% vs the prior close of $12.37.
- Volume 2.82M shares, 0.6x its 50-day average (light).
- New SEC filings: 8-K (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
LFST slides 5.1% to $11.74, a 1-month low. Closed at $11.74, -5.09% vs the prior close of $12.37. Day range $11.68–$12.49, opened at $12.45.
LFST daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — LFST slides 5.1% to $11.74, a 1-month low
- Closed at $11.74, -5.09% vs the prior close of $12.37. Day range $11.68–$12.49, opened at $12.45.
- Volume was 2.82M shares, 0.6x its 50-day average of 4.71M — lighter than usual.
- Price is -4.9% vs its 50-day average ($12.34) and +29.6% vs its 200-day average ($9.06).
- 52-week range $4.77–$13.56; today's close sits at 79% of that range, 13.4% below the 52-week high.
Oct 15, 2026 — LFST dips 1.2% to $12.37
- Closed at $12.37, -1.20% vs the prior close of $12.52. Day range $12.32–$12.62, opened at $12.53.
- Volume was 3.53M shares, 0.7x its 50-day average of 4.73M.
- Price is +0.4% vs its 50-day average ($12.32) and +36.9% vs its 200-day average ($9.03).
- 52-week range $4.77–$13.56; today's close sits at 86% of that range, 8.8% below the 52-week high.
Oct 14, 2026 — LFST rises 1.6% to $12.52
- Closed at $12.52, +1.62% vs the prior close of $12.32. Day range $12.16–$12.53, opened at $12.20.
- Volume was 3.44M shares, 0.7x its 50-day average of 4.73M.
- Price is +1.9% vs its 50-day average ($12.28) and +39.0% vs its 200-day average ($9.01).
- 52-week range $4.77–$13.56; today's close sits at 88% of that range, 7.7% below the 52-week high.
Oct 13, 2026 — LFST dips 1.3% to $12.32
- Closed at $12.32, -1.28% vs the prior close of $12.48. Day range $12.29–$12.68, opened at $12.51.
- Volume was 1.86M shares, 0.4x its 50-day average of 4.76M — lighter than usual.
- Price is +0.7% vs its 50-day average ($12.24) and +37.2% vs its 200-day average ($8.98).
- 52-week range $4.77–$13.56; today's close sits at 86% of that range, 9.1% below the 52-week high.
Oct 12, 2026 — LFST rises 0.5% to $12.48
- Closed at $12.48, +0.48% vs the prior close of $12.42. Day range $12.38–$12.54, opened at $12.45.
- Volume was 2.19M shares, 0.5x its 50-day average of 4.77M — lighter than usual.
- Price is +2.3% vs its 50-day average ($12.20) and +39.4% vs its 200-day average ($8.96).
- 52-week range $4.77–$13.56; today's close sits at 88% of that range, 8.0% below the 52-week high.
Oct 9, 2026 — LFST rises 3.0% to $12.42
- Closed at $12.42, +2.99% vs the prior close of $12.06. Day range $12.03–$12.46, opened at $12.04.
- Volume was 1.80M shares, 0.4x its 50-day average of 4.77M — lighter than usual.
- Price is +2.1% vs its 50-day average ($12.16) and +39.1% vs its 200-day average ($8.93).
- 52-week range $4.77–$13.56; today's close sits at 87% of that range, 8.4% below the 52-week high.
Oct 8, 2026 — LFST dips 0.4% to $12.06, 3 down days in a row
- Closed at $12.06, -0.41% vs the prior close of $12.11. Day range $11.85–$12.16, opened at $12.02.
- Volume was 2.36M shares, 0.5x its 50-day average of 4.78M — lighter than usual.
- Price is -0.6% vs its 50-day average ($12.13) and +35.5% vs its 200-day average ($8.90).
- 52-week range $4.77–$13.56; today's close sits at 83% of that range, 11.1% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — LFST ends flat (-0.1%) to $12.11
- Closed at $12.11, -0.08% vs the prior close of $12.12. Day range $11.96–$12.30, opened at $11.99.
- Volume was 3.65M shares, 0.8x its 50-day average of 4.75M.
- Price is +0.1% vs its 50-day average ($12.10) and +36.4% vs its 200-day average ($8.88).
- 52-week range $4.77–$13.56; today's close sits at 84% of that range, 10.7% below the 52-week high.
Oct 6, 2026 — LFST dips 0.8% to $12.12
- Closed at $12.12, -0.82% vs the prior close of $12.22. Day range $11.92–$12.32, opened at $12.20.
- Volume was 2.50M shares, 0.5x its 50-day average of 4.74M — lighter than usual.
- Price is +0.3% vs its 50-day average ($12.09) and +36.9% vs its 200-day average ($8.85).
- 52-week range $4.77–$13.56; today's close sits at 84% of that range, 10.6% below the 52-week high.
Oct 5, 2026 — LFST jumps 3.3% to $12.22
- Closed at $12.22, +3.30% vs the prior close of $11.83. Day range $11.83–$12.24, opened at $11.86.
- Volume was 3.23M shares, 0.7x its 50-day average of 4.71M.
- Price is +1.3% vs its 50-day average ($12.06) and +38.5% vs its 200-day average ($8.82).
- 52-week range $4.77–$13.56; today's close sits at 85% of that range, 9.9% below the 52-week high.
Oct 2, 2026 — LFST dips 0.7% to $11.83
- Closed at $11.83, -0.67% vs the prior close of $11.91. Day range $11.47–$12.08, opened at $11.91.
- Volume was 3.77M shares, 0.8x its 50-day average of 4.67M.
- Price is -1.7% vs its 50-day average ($12.03) and +34.5% vs its 200-day average ($8.80).
- 52-week range $4.77–$13.56; today's close sits at 80% of that range, 12.8% below the 52-week high.
LFST latest news & SEC filings
Every SEC filing by or about LFST in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Oct 5, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bourdon David gifted 150,000 shares on Sep 22, 2026; now holds 1,098,247
- Bourdon David gifted 150,000 shares on Sep 22, 2026; now holds 150,000
- Bourdon David gifted 150,000 shares on Sep 22, 2026; now holds 948,247
- Bourdon David gifted 150,000 shares on Sep 22, 2026; now holds 150,000
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Tpg Gp A, Llc sold 18,409,705 shares at $12.29 (≈$226.26M) on Sep 11, 2026
- Tpg Gp A, Llc sold 18,409,705 shares at $12.29 (≈$226.26M) on Sep 11, 2026
- Coulter James G sold 18,409,705 shares at $12.29 (≈$226.26M) on Sep 11, 2026
- Coulter James G sold 18,409,705 shares at $12.29 (≈$226.26M) on Sep 11, 2026
- Winkelried Jon sold 18,409,705 shares at $12.29 (≈$226.26M) on Sep 11, 2026
- Winkelried Jon sold 18,409,705 shares at $12.29 (≈$226.26M) on Sep 11, 2026
- …plus 6 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 10, 2026 · Form 424B7 — Prospectus supplement for a resale by holders
Prospectus supplement for a resale by holders
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 9, 2026 · Form 424B7 — Prospectus supplement for a resale by holders
Prospectus supplement for a resale by holders
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Paunovich Vukasin sold 42,067 shares at $12.87 (≈$541.40K) on Sep 2, 2026
- Paunovich Vukasin sold 42,067 shares at $12.87 (≈$541.40K) on Sep 2, 2026
- Paunovich Vukasin sold 42,067 shares at $12.87 (≈$541.40K) on Sep 2, 2026
- Paunovich Vukasin sold 42,067 shares at $12.87 (≈$541.40K) on Sep 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 2, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $435.35M (prior year $345.31M) (+26.1% vs Jun 30, 2025)
- Net income: $23.61M (prior year -$3.79M) (swung to profit vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade LFST
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 25, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.43% (largest 5.1%).
- Liquidity: about 3.59M shares (≈$42.10M) trade per day on average.
- 52-week position: $11.74 vs a range of $4.77–$13.56 (79% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Gp A, Llc Tpg sold 18,409,705 shares on Sep 11, 2026.
- Latest filings: 8-K Oct 16, 2026; 8-K Sep 11, 2026; 10-Q Aug 6, 2026.
- Share count: 382.06M shares outstanding (Jul 29, 2026), -1.8% vs a year earlier.
- Listing: Nasdaq · industry: Services-Health Services.
LFST market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 12.45 | 12.49 | 11.68 | 11.74 | 2.82M |
| Oct 15, 2026 | 12.53 | 12.62 | 12.32 | 12.37 | 3.53M |
| Oct 14, 2026 | 12.20 | 12.53 | 12.16 | 12.52 | 3.44M |
| Oct 13, 2026 | 12.51 | 12.68 | 12.29 | 12.32 | 1.86M |
| Oct 12, 2026 | 12.45 | 12.54 | 12.38 | 12.48 | 2.19M |
| Oct 9, 2026 | 12.04 | 12.46 | 12.03 | 12.42 | 1.80M |
| Oct 8, 2026 | 12.02 | 12.16 | 11.85 | 12.06 | 2.36M |
| Oct 7, 2026 | 11.99 | 12.30 | 11.96 | 12.11 | 3.65M |
| Oct 6, 2026 | 12.20 | 12.32 | 11.92 | 12.12 | 2.50M |
| Oct 5, 2026 | 11.86 | 12.24 | 11.83 | 12.22 | 3.23M |
| Oct 2, 2026 | 11.91 | 12.08 | 11.47 | 11.83 | 3.77M |
| Oct 1, 2026 | 12.04 | 12.25 | 11.84 | 11.91 | 3.71M |
| Sep 30, 2026 | 11.85 | 12.17 | 11.85 | 12.03 | 3.29M |
| Sep 29, 2026 | 11.85 | 11.90 | 11.60 | 11.89 | 3.45M |
| Sep 28, 2026 | 11.77 | 11.99 | 11.70 | 11.84 | 3.04M |
| Sep 25, 2026 | 11.77 | 12.05 | 11.76 | 11.84 | 7.83M |
| Sep 24, 2026 | 12.13 | 12.17 | 11.78 | 11.80 | 4.26M |
| Sep 23, 2026 | 12.50 | 12.51 | 11.75 | 12.08 | 7.62M |
| Sep 22, 2026 | 12.69 | 12.91 | 12.52 | 12.55 | 4.04M |
| Sep 21, 2026 | 12.56 | 12.72 | 12.40 | 12.67 | 3.31M |
About LifeStance Health
LifeStance Health (LFST) is listed on the Nasdaq and classified by the SEC under “Services-Health Services”. Its business address is in SCOTTSDALE, AZ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1845257.
LFST board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Darren M. Black | Director | May 14, 2026 |
| Robert Bessler | Director | Jul 7, 2026 |
| David Bourdon | Chief Executive Officer | Sep 24, 2026 |
| Kenneth A Burdick | Director | Aug 13, 2026 |
| Teresa Deluca | Director | Aug 18, 2026 |
| Lori Goltermann | Director | Jul 7, 2026 |
| Thurman Justice | Director | Jul 7, 2026 |
| Eric P Palmer | Director | Jul 7, 2026 |
| Ryan Pardo | See Remarks | Apr 3, 2026 |
| Sarah Personette | Director | Jul 7, 2026 |
| Safwan Shabab | Director | Jul 7, 2026 |
| Eric Shuey | Director | May 14, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| David Bourdon | Chief Executive Officer | Sep 24, 2026 |
| Stephanie Carin Eken | Chief Medical Officer | Mar 9, 2026 |
| Ryan Mcgroarty | See Remarks | Mar 26, 2026 |
| Lisa K Miller | Chief Operating Officer | Aug 12, 2026 |
| Ryan Pardo | See Remarks | Apr 3, 2026 |
| Vukasin Paunovich | Chief Technology Officer | Sep 4, 2026 |
| Ann Varanakis | Chief People Officer | Aug 26, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 11, 2026 | Gp A, Llc Tpg | Sale | 18,409,705 | $12.29 |
| Sep 11, 2026 | Gp A, Llc Tpg | Sale | 18,409,705 | $12.29 |
| Sep 11, 2026 | James G Coulter | Sale | 18,409,705 | $12.29 |
| Sep 11, 2026 | James G Coulter | Sale | 18,409,705 | $12.29 |
| Sep 11, 2026 | Jon Winkelried | Sale | 18,409,705 | $12.29 |
| Sep 11, 2026 | Jon Winkelried | Sale | 18,409,705 | $12.29 |
| Sep 11, 2026 | Gp A, Llc Tpg | Sale | 18,409,705 | $12.29 |
| Sep 11, 2026 | Gp A, Llc Tpg | Sale | 18,409,705 | $12.29 |
| Sep 11, 2026 | James G Coulter | Sale | 18,409,705 | $12.29 |
| Sep 11, 2026 | James G Coulter | Sale | 18,409,705 | $12.29 |
| Sep 11, 2026 | Jon Winkelried | Sale | 18,409,705 | $12.29 |
| Sep 11, 2026 | Jon Winkelried | Sale | 18,409,705 | $12.29 |
| Sep 2, 2026 | Vukasin Paunovich | Sale | 42,067 | $12.87 |
| Sep 2, 2026 | Vukasin Paunovich | Sale | 42,067 | $12.87 |
| Sep 2, 2026 | Vukasin Paunovich | Sale | 42,067 | $12.87 |
LFST financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $9.66M | — | $146.15M |
| Dec 31, 2024 | — | $-57.44M | — | $107.26M |
| Dec 31, 2023 | — | $-186.26M | — | $-16.88M |
| Dec 31, 2022 | — | $-215.56M | — | $52.79M |
| Dec 31, 2021 | $1.45M | $-307.20M | — | $9.42M |
Latest balance sheet: total assets $2.18B, total liabilities $704.35M, cash $225.94M (as of Jun 30, 2026).
LFST earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $10.66 |
| May 7, 2026 | 8-K Item 2.02 (results) | $8.85 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $7.41 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $6.25 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $3.86 |
| May 7, 2025 | 8-K Item 2.02 (results) | $5.51 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $7.74 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $7.68 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Feb 28, 2024 | 8-K Item 2.02 (results) | — |
| Feb 2, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Health Services
GeneDx (WGS)Privia Health (PRVA)Omada Health (OMDA)U S Physical Therapy (USPH)Pennant (PNTG)InnovAge (INNV)Strata Critical Medical (SRTA)EUDA Health (EUDA)DocGo (DCGO)Agape ATP (ATPC)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on LFST
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.